Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Undervalued vs peers
About
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced on P/FCF
Target Price
The average target price of INDV.L is 1002 and suggests 19% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell